U.S. Securities & Exchange Commission Pixel
SEC Seal
US Flag background Home | FAQ Pixel
Pixel
U.S. Securities and Exchange Commission Pixel
Pixel
US Flag background Pixel Pixel
Pixel Banner Seal Bottom Front

Full-Text Search

This page allows you to search the full text of EDGAR filings from the last four years. The full text of a filing includes all data in the filing as well as all attachments to the filing. To find the information you need and make your search easy and enjoyable, please visit our FAQ page. We are still developing this feature, and we plan to enhance it based on user feedback. Please email your comments and suggestions for improvement to textsearch@sec.gov.

Note: Occasionally, some recent filings are not available through the EDGAR Full-Text Search.


Pixel Pixel
: Basic Search Page
: :
:
:
:
:
 Click here for Calendar  Click here for Calendar

Date Filed Title
03/25/2019PRE 14A for CTI BIOPHARMA CORP    
 COMPANY NAME(s) - [CTI BIOPHARMA CORP (CIK - 891293 /SIC - 2834)]
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant: Filed by a Party other than the Registrant: Check the appropriate box: Preliminary Proxy
 
03/25/2019PREM14A for AmpliPhi Biosciences Corp    
 COMPANY NAME(s) - [AmpliPhi Biosciences Corp (CIK - 921114 /SIC - 2836)]
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary
 
03/25/2019DEF 14A for PULTEGROUP INC MI    
 COMPANY NAME(s) - [PULTEGROUP INC MI (CIK - 822416 /SIC - 1531)]
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by
 
03/25/2019DEF 14A for GILEAD SCIENCES INC    
 COMPANY NAME(s) - [GILEAD SCIENCES INC (CIK - 882095 /SIC - 2836)]
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant CHECK THE APPROPRIATE BOX:
 
03/25/2019DEF 14A for Discover Financial Services    
 COMPANY NAME(s) - [Discover Financial Services (CIK - 1393612 /SIC - 6141)]
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the
 
03/25/2019EX-99.1 of 8-K/A for GENEREX BIOTECHNOLOGY CORP    
 COMPANY NAME(s) - [GENEREX BIOTECHNOLOGY CORP (CIK - 1059784 /SIC - 2834)]
 Financial Statements As of and for the Years Ended December 31, 2017 and 2016 1 Regentys Corporation Financial Statements As of and for the Years Ended December 31, 2017 and 2016 2 Regentys Corporation Contents
 
03/25/2019EX-99.2 of 8-K/A for GENEREX BIOTECHNOLOGY CORP    
 COMPANY NAME(s) - [GENEREX BIOTECHNOLOGY CORP (CIK - 1059784 /SIC - 2834)]
 Condensed Financial Statements As of September 30, 2018 and December 31, 2017 and for the Nine Months Ended September 30, 2018 and 2017 1 Regentys Corporation Condensed Financial Statements As of September 30, 2018 and December 31, 2017 and for the Nine Months Ended
 
03/25/201910-K for DarioHealth Corp    
 COMPANY NAME(s) - [DarioHealth Corp (CIK - 1533998 /SIC - 3841)]
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF
 
03/25/2019PRE 14A for MARRIOTT INTERNATIONAL INC MD    
 COMPANY NAME(s) - [MARRIOTT INTERNATIONAL INC MD (CIK - 1048286 /SIC - 7011)]
 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a party
 
03/25/2019S-1/A for Silk Road Medical Inc    
 COMPANY NAME(s) - [Silk Road Medical Inc (CIK - 1397702 /SIC - 3841)]
 If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.